Akebia Therapeutics reported $24.94M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 10.77M 3.89M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Akebia Therapeutics AKBA:US $ 24.94M 5.48M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Astellas Pharma 4503:JP Y 152220M 21481M
Avrobio Inc AVRO:US 4.04M 551K
Bayer BAYN:GR 5.85B 945M
Exelixis EXEL:US $ 17.28M 6.97M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
Ironwood Pharmaceuticals IRWD:US $ 0.32M 0.22M
Moderna Inc MRNA:US 181M 18M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Opko Health OPK:US $ 56.11M 38.13M
Prothena PRTA:US 9.32M 5.62M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Vanda Pharmaceuticals VNDA:US $ 5.55M 0.45M